About these studies
The BE OPTIMAL and BE COMPLETE studies are testing whether an investigational study drug called bimekizumab is safe and effective for treating active psoriatic arthritis.
- Are 18 years of age or older
- Have been diagnosed with active psoriatic arthritis
- Have had psoriatic arthritis for at least 6 months
- Have at least 1 psoriatic lesion and/or a history of psoriasis
then you may be able to take part.*
*Other medical criteria must be met before you can join one of these studies; these will be assessed by the study team.